A strong economic framework
Facts & Figures

1Accounting for 46%

of all exports, the EU was the Swiss pharmaceutical industry's biggest trading partner in 2019.

Leading in research & development
Facts & Figures

40 to 80

The chances of a cure for cancer in children have risen from 40% to 80% between 1973 and 2012.

A strong economic framework
Messages

The pharmaceutical industry in Switzerland will also need attractive framework conditions in future, including legal certainty, open export markets and the availability of labour.

Healthcare system
Messages

People in Switzerland benefit from access to high-quality healthcare provision. However, there is still a need for action and improvement in various areas.

show more articles

About us

Interpharma, the association of Switzerland’s research-based pharmaceutical industry, was founded in Basel in 1933.

Interpharma informs the public about issues that are important to the research-based pharmaceutical industry in Switzerland, including the pharma market in Switzerland, healthcare and biomedical research.

Annual report

Information on our key figures and activities in the financial year 2019

read more

Board and Executive Management

Introducing Interpharma

read more

Vision and Mission

More about the tasks and overriding aims of Interpharma

read more

Contact

Contact us

read more

Media

Latest information and media contacts for media representatives

read more